SHARON WHITE: Open Payments
NPI 1215293378 · MALDEN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 9 payments from 6 companies in 2025. Trend: 2023 $89 · 2024 $0 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Eisai Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Novo Nordisk Inc | 1 | $17 |
Products named: REXULTI, LEQVIO, Leqembi, Kerendia, CAPLYTA.
Industry payments across MO — which companies pay providers there.
